26.81
price up icon9.83%   2.40
after-market Handel nachbörslich: 26.75 -0.06 -0.22%
loading
Schlusskurs vom Vortag:
$24.41
Offen:
$24.71
24-Stunden-Volumen:
2.52M
Relative Volume:
1.10
Marktkapitalisierung:
$2.80B
Einnahmen:
$742.53M
Nettoeinkommen (Verlust:
$-32.56M
KGV:
-99.30
EPS:
-0.27
Netto-Cashflow:
$32.61M
1W Leistung:
+10.33%
1M Leistung:
+20.77%
6M Leistung:
+1.51%
1J Leistung:
+106.23%
1-Tages-Spanne:
Value
$24.61
$27.10
1-Wochen-Bereich:
Value
$22.54
$29.73
52-Wochen-Spanne:
Value
$12.46
$29.73

Warby Parker Inc Stock (WRBY) Company Profile

Name
Firmenname
Warby Parker Inc
Name
Telefon
(646) 847-7215
Name
Adresse
233 SPRING STREET, NEW YORK
Name
Mitarbeiter
3,780
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
WRBY's Discussions on Twitter

Vergleichen Sie WRBY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
WRBY
Warby Parker Inc
26.81 2.98B 742.53M -32.56M 32.61M -0.27
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
482.35 171.42B 9.15B 2.61B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
195.96 55.88B 21.39B 1.59B 2.55B 5.56
Medical Instruments & Supplies icon
ALC
Alcon Inc
86.48 42.55B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
288.28 41.48B 5.15B 1.40B 1.65B 9.51
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
246.22 17.25B 2.90B 467.20M 306.90M 6.37

Warby Parker Inc Stock (WRBY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-01 Bestätigt Telsey Advisory Group Outperform
2025-07-10 Herabstufung Citizens JMP Mkt Outperform → Mkt Perform
2025-04-30 Hochstufung Citigroup Sell → Neutral
2025-04-17 Hochstufung Loop Capital Hold → Buy
2025-02-28 Bestätigt Telsey Advisory Group Outperform
2025-02-25 Eingeleitet ROTH MKM Neutral
2025-02-05 Herabstufung Citigroup Neutral → Sell
2025-01-17 Herabstufung Evercore ISI Outperform → In-line
2024-11-19 Bestätigt Telsey Advisory Group Outperform
2024-11-08 Bestätigt Telsey Advisory Group Outperform
2024-11-07 Hochstufung William Blair Mkt Perform → Outperform
2024-10-21 Hochstufung Goldman Neutral → Buy
2024-08-23 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2024-08-23 Fortgesetzt Piper Sandler Overweight
2023-10-12 Hochstufung BTIG Research Neutral → Buy
2023-10-03 Hochstufung Evercore ISI In-line → Outperform
2023-09-25 Eingeleitet UBS Neutral
2023-06-27 Eingeleitet William Blair Mkt Perform
2023-05-24 Eingeleitet JMP Securities Mkt Perform
2023-03-01 Herabstufung Citigroup Buy → Neutral
2023-02-07 Eingeleitet BTIG Research Neutral
2022-12-15 Eingeleitet Wolfe Research Outperform
2022-07-22 Eingeleitet Piper Sandler Overweight
2022-05-18 Herabstufung Goldman Buy → Neutral
2022-03-31 Eingeleitet Stifel Hold
2021-10-26 Eingeleitet Citigroup Buy
2021-10-25 Eingeleitet Cowen Outperform
2021-10-25 Eingeleitet Evercore ISI In-line
2021-10-25 Eingeleitet Goldman Buy
2021-10-25 Eingeleitet Morgan Stanley Equal-Weight
2021-10-25 Eingeleitet Robert W. Baird Outperform
2021-10-25 Eingeleitet Telsey Advisory Group Outperform
Alle ansehen

Warby Parker Inc Aktie (WRBY) Neueste Nachrichten

pulisher
02:22 AM

How Warby Parker’s Rising Sales and Leadership Changes Could Shape the WRBY Investment Story - simplywall.st

02:22 AM
pulisher
Aug 12, 2025

Warby Parker’s Earnings Call: Growth and Strategic Moves - TipRanks

Aug 12, 2025
pulisher
Aug 11, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cytek Biosciences (CTKB), Natera (NTRA) and Warby Parker (WRBY) - The Globe and Mail

Aug 11, 2025
pulisher
Aug 11, 2025

Warby Parker Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Warby Parker Gets Price Target Hikes On Strong Q2 Report, Google AI Glasses Optimism - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Citizens JMP reiterates Market Perform rating on Warby Parker stock By Investing.com - Investing.com Canada

Aug 11, 2025
pulisher
Aug 11, 2025

Citizens JMP reiterates Market Perform rating on Warby Parker stock - Investing.com

Aug 11, 2025
pulisher
Aug 10, 2025

Mixed Analyst Opinions on Healthcare Stocks Cytek Biosciences, Natera, and Warby Parker - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

How Warby Parker Has Kept the Price of Glasses at $95 for 15 YearsWSJ - The Wall Street Journal

Aug 10, 2025
pulisher
Aug 09, 2025

Warby Parker raises 2025 revenue guidance to up to $888M as Google AI eyewear partnership and store expansion drive growth - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Compared to Estimates, Warby Parker (WRBY) Q2 Earnings: A Look at Key Metrics - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Warby Parker Inc. (NYSE:WRBY) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 09, 2025
pulisher
Aug 09, 2025

How to build a dashboard for Warby Parker Inc. stockFree Real Time Alerts Based on AI Prediction - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

What MACD signals say about Warby Parker Inc.Free Real Trader Watchlist of Hot Stocks - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Real time alert setup for Warby Parker Inc. performanceSmart Entry Signals for Active Traders - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Warby Parker 2025 Q2 Earnings Strong Performance as Net Income Surges 74.1% - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Historical volatility pattern of Warby Parker Inc. visualizedInvestment Position Summary with Timeframe Forecast - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Using data filters to optimize entry into Warby Parker Inc.Expert-Backed High Yield Stock Watchlist - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

What data driven models say about Warby Parker Inc.’s futureAlpha Stock Picks with Chart Confirmation - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Is now a turning point for Warby Parker Inc.Daily Trade Setup Forecast with Confidence - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

CFOs On the Move: Week ending Aug. 8 - CFO.com

Aug 08, 2025
pulisher
Aug 08, 2025

UBS Hikes Price Target on Warby Parker to $23 From $20, Maintains Neutral Rating - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Warby Parker CFO Steve Miller Resigns - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

Stifel raises Warby Parker stock price target to $22 on improved outlook - Investing.com Australia

Aug 08, 2025
pulisher
Aug 08, 2025

Warby Parker Inc. SEC 10-Q Report - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Warby Parker Inc (WRBY) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Aug 08, 2025
pulisher
Aug 08, 2025

Zurcher Kantonalbank Zurich Cantonalbank Sells 64,236 Shares of Warby Parker Inc. (NYSE:WRBY) - Defense World

Aug 08, 2025
pulisher
Aug 08, 2025

Warby Parker Reports Strong Q2 2025 Results - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Warby Parker Reports Revenue Growth for Q2, Raises Full-Year Outlook and Announces Leadership Update - VisionMonday.com

Aug 08, 2025
pulisher
Aug 08, 2025

Q2 Earnings Forecast for Warby Parker Issued By Roth Capital - Defense World

Aug 08, 2025
pulisher
Aug 07, 2025

Warby Parker's Dual-Engine Growth Strategy: AI-Integrated Innovation and Physical Expansion Redefine Eyewear Market - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker's Q2 2025: Unpacking Contradictions in Economic Outlook, Customer Stability, and Growth Strategies - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

WRBY’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker’s Strategic Growth Amidst External Challenges: A Hold Rating Analysis - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker Shares Slip After Giving Up Early Gains Despite Strong Q2 Results and Raised Outlook - Benzinga

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker’s (NYSE:WRBY) Q2 Sales Top Estimates - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker stock price target raised to $28 by BTIG on Q2 beat - Investing.com Australia

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings call transcript: Warby Parker Q2 2025 misses EPS forecasts, revenue grows - Investing.com Canada

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker to end home try-on program as it focuses on stores, digital experience - Retail Dive

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker’s Strong Financial Performance and Growth Prospects Amid CFO Transition - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker Soars 7.22%—Is This the Dawn of a New Retail Era? - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker Q2 2025 slides: 14% revenue growth, raises full-year outlook - Investing.com Canada

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker stock hits 52-week high at 29.32 USD By Investing.com - Investing.com Australia

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker's Strategic Turnaround: A Glimpse of Profitability and AI-Driven Growth in a Competitive Market - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker reports Q2 EPS (1c), consensus 7c - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker Q2 Loss Narrows, Revenue Rises; Lifts 2025 Outlook - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker 2Q Earnings Beat Expectations, CFO to Step Down - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Warby Parker 2Q Loss Narrows as Revenue Rises; Finance Chief to Step Down - MarketScreener

Aug 07, 2025

Finanzdaten der Warby Parker Inc-Aktie (WRBY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$145.74
price up icon 3.74%
medical_instruments_supplies BAX
$24.11
price up icon 0.54%
$74.38
price up icon 3.18%
medical_instruments_supplies COO
$74.27
price up icon 2.17%
$68.98
price up icon 1.52%
medical_instruments_supplies WST
$246.22
price up icon 2.63%
Kapitalisierung:     |  Volumen (24h):